Vista de Recomendaciones sobre la vacunación contra SARS-CoV-2 en pacientes en diálisis y lista de espera de trasplante renal
datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
dc.contributor.author | Yomayusa González, Nancy | |
dc.contributor.author | González González, Camilo Alberto | |
dc.contributor.author | Yama, Erica | |
dc.contributor.author | Aroca Martínez, Gustavo | |
dc.contributor.author | Chacón Acevedo, Kelly Rocío | |
dc.contributor.author | Robayo, Adriana | |
dc.contributor.author | Baquero Rodríguez, Richard | |
dc.contributor.author | Montero, Camilo | |
dc.contributor.author | Torres Serrano, Rodolfo Eduardo | |
dc.contributor.author | Restrepo, Cesar | |
dc.contributor.author | Benavidez, Carlos | |
dc.contributor.author | Coronado Daza, Jorge Antonio | |
dc.contributor.author | Castelo Meza, Sandra | |
dc.contributor.author | Ariza García, Amaury Miguel | |
dc.contributor.author | Mercado, Álvaro | |
dc.contributor.author | Ballesteros, David Andrés | |
dc.contributor.author | Muñoz, Germán | |
dc.contributor.author | Guerrero Tinoco, Gustavo Adolfo | |
dc.contributor.author | Zapata Chica, Carlos Andrés | |
dc.contributor.author | Carrascal Guzmán, Martha Isabel | |
dc.contributor.author | Mejía, Natalia | |
dc.contributor.author | Rodríguez Sánchez, Martha Patricia | |
dc.contributor.author | Rico Fontalvo, Jorge Eduardo | |
dc.contributor.author | Ramírez Marmolejo, Roberto | |
dc.contributor.author | Vargas, Juan Guillermo | |
dc.contributor.author | Acevedo Velasco, Andrés David | |
dc.contributor.author | Pérez, Jorge | |
dc.contributor.author | Gayón, Diana | |
dc.contributor.author | Borraez Ramos, Deisy Mayerleth | |
dc.contributor.author | Larrarte Arenas, Carolina | |
dc.contributor.author | Ferreiro-Fuentes, Alejandro | |
dc.date.accessioned | 2023-01-10T21:37:40Z | |
dc.date.available | 2023-01-10T21:37:40Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Contexto: las personas con diálisis se consideran una población de alto riesgo de infección por SARS-CoV-2, complicaciones y muerte. En Colombia, cerca del 44 % de la población en diálisis es menor de 60 años, adicionalmente, por los mismos retos que ha impuesto la pandemia a los programas de trasplantes, se ha incrementado notoriamente la población joven que debe seguir en diálisis al no tener opción a corto plazo de un trasplante renal, por lo tanto, las limitaciones en el acceso temprano a la vacunación contra SARS-CoV-2 agudizarían los problemas de esta población, provocando pérdidas considerables en años de vida que la vacuna podría salvar. Objetivo: el objetivo del presente documento es sintetizar los principales motivos por los que se recomienda la priorización de la vacunación de los pacientes en diálisis crónica y lista de espera para trasplante renal. Métodología: se realizó una búsqueda rápida de información sobre la vacunación en pacientes con ERC en diálisis o en espera de trasplante renal. La información resultante fue analizada críticamente por expertos en nefrología para la formulación de recomendaciones. Los resultados de la búsqueda se presentan a manera de síntesis narrativa. Resultados: a partir de la información revisada y discutida por los expertos en nefrología se proponen 4 recomendaciones para la vacunación contra el virus SARS-Cov-2. Conclusiones: la Asociación Colombiana de Nefrología e Hipertensión Arterial, la Asociación Colombiana de Nefrología Pediátrica y la Asociación Colombiana de Trasplante de Órganos, comprometidos con la salud de los pacientes con enfermedad renal en diálisis y listas de espera de trasplantes en Colombia, se unen a la solicitud mundial de generar recomendaciones para la vacunación contra SARS-CoV-2. | spa |
dc.description.abstract | Background: People on dialysis are considered a high-risk population for SARS-CoV-2 infection, complications, and death. In Colombia, about 44 % of the population on dialysis is under 60 years of age. In addition, due to the same challenges that the pandemic has imposed on transplant programs, the young population that must continue on dialysis has increased markedly, as they have no option in the short term of a kidney transplant, therefore, the limitations in early access to vaccination against SARS-CoV-2 would exacerbate the problems of this population, causing considerable losses in years of life that the vaccine could save. Purpose: The objective of this document is to summarize the main reasons why the prioritization of vaccination of patients on chronic dialysis and on the kidney transplant waiting list is recommended. Methodology: A rapid search for information on vaccination in patients with CKD on dialysis or awaiting kidney transplantation was performed. The resulting information was critically analyzed by experts in nephrology for the formulation of recommendations. The search results are presented as a narrative synthesis. Results: Based on the information reviewed and discussed by nephrology experts, 4 recommendations are proposed for vaccination against the SARS-Cov-2 virus. Conclusions: The Colombian Association of Nephrology and Arterial Hypertension (ASOCOLNEF), the Colombian Association of Pediatric Nephrology (ACONEPE) and the Colombian Association of Organ Transplantation (ACTO), committed to the health of patients with kidney disease on dialysis and transplant waiting lists in Colombia, join to generate recommendations for prioritization and vaccination against SARS-CoV-2 | eng |
dc.format.mimetype | spa | |
dc.identifier.doi | http://dx.doi.org/10.22265/acnef.9.2.600 | |
dc.identifier.issn | 25005006 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12442/11676 | |
dc.identifier.url | https://www.revistanefrologia.org/index.php/rcn/article/view/600/968 | |
dc.language.iso | spa | spa |
dc.publisher | Asociación Colombiana de Nefrología e Hipetensión Arterial | spa |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | Revista Colombiana de Nefrología | |
dc.source | Rev. Colomb. Nefrol. | |
dc.source | Vol. 9 No. 2 Año (2022) | |
dc.subject | Vacuna | spa |
dc.subject | Infecciones por coronavirus | spa |
dc.subject | Diálisis | spa |
dc.subject | Insuficiencia renal crónica | spa |
dc.subject | Trasplante de riñón | spa |
dc.subject | Chronic Kidney | eng |
dc.subject | Chronic Kidney Disease-Mineral and Bone Disorder | eng |
dc.subject | Renal Insufficiency Chronic | eng |
dc.subject | Quality of Life | eng |
dc.subject | Consensus | eng |
dc.subject | Diagnosis | eng |
dc.subject | Therapeutics | eng |
dc.title | Vista de Recomendaciones sobre la vacunación contra SARS-CoV-2 en pacientes en diálisis y lista de espera de trasplante renal | spa |
dc.title.translated | Recommendations on the vaccination against SARS-CoV-2 in patients on dialysis and on the kidney transplant waiting list | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.spa | Artículo científico | spa |
dcterms.references | Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Post discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020 jul. 93(2):1013-22. https://doi.org/10.1002/jmv.26368 | eng |
dcterms.references | De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye M. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacementtherapy: a region wide registry study. J Am Soc Nephrol. 2021; 32:385-96. https://doi.org/10.1681/ASN.2020060875 | eng |
dcterms.references | Peck M et al. Global routine vaccination coverage [Internet]. Available from: https://www. cdc.gov/mmwr/volumes/68/wr/mm6842a1.htm?s cid=mm6842a1 x | eng |
dcterms.references | WHO. Immunization coverage [Internet]. 2020. Disponible en: http://www.who.int/ news-room/fact-sheets/detail/immunization-coverage | eng |
dcterms.references | Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. A Novel Coronavirus Genome Identi ed in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020. China CDC Wkly. 2020;2(4):61- 2. https://doi.org/10.46234/ccdcw2020.017 | eng |
dcterms.references | WHO. Draft landscape of COVID-19 candidate vaccines [Internet]. 2020. Disponible en: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines | eng |
dcterms.references | Francis A, Baigent C, Ikizler TA, Cockwell P, Jha V. The urgent need to vaccinate dialysis patients against SARS-CoV-2: A call to action. Kidney Int. 2021;99(4):791-3. https://doi.org/ 10.1016/j.kint.2021.02.003 | eng |
dcterms.references | National Kidney Foundation. Position Statement on Kidney Patient Prioritization for COVID-19 Vaccines and Therapeutics [Internet]. 2021. Disponible en: https://www.kidney. org/sites/default/ les/nkf statement vaccine distribution nal 20201216.pdf | eng |
dcterms.references | Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nature Rev Nephrol. 2020;16(12):705-6. https://doi.org/10.1038/s41581-020-00349-4 | eng |
dcterms.references | Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi. org/10.1016/S0140-6736(20)30183-5 | eng |
dcterms.references | Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430-6. https:// doi.org/10.1038/s41586-020-2521-4 | eng |
dcterms.references | Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol. 2020;1-2. https://doi.org/10.1038/s41581-020-00381-4 | eng |
dcterms.references | Sim JJ, Huang CW, Selevan DC, Chung J, Rutkowski MP, Zhou H. COVID-19 and Survival in Maintenance Dialysis. Kidney Med. 2020. https://doi.org/10.1016/j.xkme.2020.11.005 | eng |
dcterms.references | González C, Yama E, Yomayusa N, Vargas J, Rico J, Ariza A, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, el diagnóstico y el manejo de la lesión renal aguda por SARS- CoV-2/COVID-19. Rev Colomb Nefrol. 2020;7(supl. 2). https://doi.org/10.22265/acnef.7.Supl.2.473 | spa |
dcterms.references | Yomayusa N, Yama E, González C, Ariza A, Aroca G, Baquero R, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, diagnóstico y manejo de infección por SARS-CoV-2/COVID-19 en pacientes con Enfermedad Renal Crónica en diálisis. Rev Colomb Nefrol. 2020 jul.;7(supl. 2). https://doi.org/ 10.22265/acnef.7.Supl.2.474 | spa |
dcterms.references | Baquero R, Yomayusa N, González C, Yama E, Vargas JG, Rico J, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, diagnóstico y manejo de la infección por SARS- CoV-2/COVID-19 en paciente pediátrico con enfermedad renal crónica o lesión renal aguda asociada a COVID-19. Rev Colomb Nefrol. 2020 jul.;7(supl. 2). https://doi.org/10.22265/acnef.7.Supl.2.488 | spa |
dcterms.references | Cuenta de Alto Costo (CAC). Situación de la enfermedad Renal Crónica, Hipertensión arterial y Diabetes Mellitus en Colombia. 2018. Disponible en: https://cuentadealtocosto.org/site/publicaciones/ situacion-de-la-enfermedad-renal-cronica-la-hipertension-arterial-y-la-diabetes-mellitus\ -en-colombia-2018/ | spa |
dcterms.references | Khatri M, Islam S, Dutka P, Carson J, Drakakis J, Imbriano I, et al. COVID-19 Antibodies and Outcomes among Outpatient Maintenance Hemodialysis Patients. Kidney360. 2021;2(2):263-9. https://doi.org/10.34067/KID.0006292020 | eng |
dcterms.references | Couchoud C, Bayer F, Ayav C, Béchade C, Brunet P, Chantrel F, et al. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients. Kidney Int. 2020;98(6):1519-29. https://doi.org/10.1016/j.kint.2020.07.042 | eng |
dcterms.references | Weiss S, Bhat P, Del Pilar-Fernández M, Bhat JG, Coritsidis GN. COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Programat Dialysis Facilities in New York City and Long Island. J Am Soc Nephrol. 2020;31(11):2517-21. https://doi.org/10. 1681/ASN.2020070932 | eng |
dcterms.references | Hsu CM, Weiner DE, Aweh G, Miskulin D, Manley H, Stewart C, et al. COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider. Am J Kidney Dis. 2021;77(5):748-56. https://doi.org/10.1053/j.ajkd.2021.01.003 | eng |
dcterms.references | Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV2 infection. Kidney Int. 2020;98(1):20-6. https://doi.org/ 10.1016/j.kint.2020.04.030 | eng |
dcterms.references | Corbett RW, Blakey S, Nitsch D, Loucaidou M, McLean A, Duncan N, et al. Epidemiology of COVID-19 in an Urban Dialysis Center. J Am Soc Nephrol. 2020;31(8):1815-23. https:// doi.org/10.1681/ASN.2020040534 | eng |
dcterms.references | Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6):1530-9. https://doi.org/10.1016/j.kint.2020.07.030 | eng |
dcterms.references | Turgutalp K, Ozturk S, Arici M, Eren N, Gorgulu N, Islam N, et al. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021;22(1):29. https://doi.org/10.1186/s12882-021-02233-0 | eng |
dcterms.references | Ozturk S, Turgutalp K, Arici M, Odabas A, Altiparmal M, Audin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transpl. 2020;35(12):2083-95. https://doi.org/10.1093/ndt/gfaa271 | eng |
dcterms.references | Flythe JE, Assimon MM, Tugman MJ, Chang E, Gupta S, Shah J, et al. Characteristics and Outcomes of Individuals with Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021;77(2):190-203. https:// doi.org/10.1053/j.ajkd.2020.09.003 | eng |
dcterms.references | Savino M, Casula A, Santhakumaran S, Pitcher D, Wong E, Magadi W, et al. Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARSCoV-2: a UK Renal Registry data analysis. PLoS One. 2020;15:e0241263. https://doi.org/10.1371/journal.pone.0241263 | eng |
dcterms.references | Arias-Murillo YR, Benavides CA, Salinas MA, Osorio-Arango K, Plazas-Sierra C, Cortés JA. SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in Colombia. Transplant Proc. 2021;53(4):1237-44. https://doi.org/ 10.1016/j.transproceed.2020.12.003 | eng |
dcterms.references | Pastor-Barriuso R, Pérez-Gómez B, Hernán MA, Pérez-Olmeda M, Yotti R, Oteo-Iglesias J, et al. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study. BMJ. 2020 nov. 27;371. https://doi.org/10.1136/bmj. m4509 | eng |
dcterms.references | Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, et al. An initial report from the French SOT COVID registry suggest high mortality due to COVID 19 in recipients of kidney transplant. Kidney Int. 2020;98:1549-58. https://doi.org/10.1016/j.kint. 2020.08.005 | eng |
dcterms.references | Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, et al. Covid-19 and Kidney Transplantation. N Engl J Med. 2020;382(25):2475-7. https://doi.org/10.1056/ NEJMc2011117 | eng |
oaire.version | info:eu-repo/semantics/draft | spa |